Altimmune

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$6.75
Previous Close
$6.79
Day Range
$6.64-$6.81
52W Range
$2.31-$14.84
Market Cap
$479M
Shares Short
22M

Financials

See more
Revenue (12 Mos)
$409,000
Revenue Growth (YoY)
-16.7%
Gross Profit (12 Mos)
-$70.5M
Diluted EPS
-$1.63

News

See more

Yahoo Finance • 6 months ago

3 Monster Stocks in the Making You Can Buy Right Now

Yahoo Finance • 10 months ago

16 Most Promising Long-Term Stocks According to Analysts

Yahoo Finance • 12 months ago

Altimmune Announces Third Quarter 2023 Financial Results and Provides a Business Update

Yahoo Finance • last year

Altimmune Granted Fast Track Designation by FDA for Pemvidutide for the Treatment of Non-Alcoholic Steatohepatitis (NASH)

About

CEO
Dr. Vipin K. Garg Ph.D.
CFO
Mr. Andrew Shutterly M.S.
Address
910 Clopper Road, Gaithersburg, MD, United States, 20878
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
59